The Commonwealth Scientific and Industrial Research Organisation (CSIRO) has received a license to work with local Australian biomedical companies to “extract, synthesise, improve and then develop manufacturing processes” for up to 15 different psychedelic compounds.
The organisation will first be collaborating with Melbourne Natural MedTech which is “working to develop psychedelic treatments for several unmet neurological disorders,” said Natural MedTech CEO Mark Hestermann.
The company is working with CSIRO’s Kick-Start program to further explore psychedelics, also known as hallucinogens derived from plants and fungi for medical use.
“By working with local industry to improve drug design and the patient experience, CSIRO can push Australia into a leadership position in the development of these potentially life-changing medications,” said CSIRO scientist Peter Duggan on May 18….
RSS Feed | The Epoch Times